|
M.A. Osadchuk (1), D.V. Balashov (1), M.M. Osadchuk (2)
TACTICS OF MANAGEMENT OF PATIENTS WITH FUNCTIONAL DYSPEPSIA IN THE CONTEXT OF THE ROME CONSENSUS IV
|
№18 / 2016
|
|
V.N. Larina, M.V. Leonova, I.I. Chukaeva
NEW EUROPEAN GUIDELINES ON PHARMACOTHERAPY OF CHRONIC HEART FAILURE AND EVIDENCE-BASED DATA
|
№18 / 2016
|
|
A.A. Samsonov, D.N. Andreev, V.A. Shestakov
CHRONIC DUODENITIS AS ACTUAL PROBLEMS OF PATHOLOGY OF THE UPPER GASTROINTESTINAL TRACT: ISSUES OF CLASSIFICATION AND TREATMENT
|
№18 / 2016
|
|
E.D. Belousova (1, 2)
INFLUENCE OF ANTIEPILEPTIC DRUGS ON MOOD AND BEHAVIOR OF THE PATIENTS WITH EPILEPSY
|
№13 / 2016
|
|
Yu.E. Nesterov, N.N. Zavadenko
MODERN PRINCIPLES OF PROPHYLACTIC THERAPY OF MIGRAINE IN CHILDREN AND ADOLESCENTS
|
№9 / 2016
|
|
A. V. Starodubova, O. A. Kislyak
OBESITY AS A RISK FACTOR FOR CARDIOVASCULAR DISEASES. LITERATURE REVIEW
|
№17 / 2015
|
|
Zh.A. Mironova, V.I. Trofimov
PHARMACOTHERAPY OF SEVERE BRONCHIAL ASTHMA
|
№10 / 2015
|
|
V.V. Cukanov (1), E.V. Onuchina (2), E.V. Kasparov (1), A.V. Vasjutin (1), Ju.L. Tonkih (1)
CLINICAL EXPERIENCE WITH LONG-TERM TREATMENT OF PATIENTS WITH BARRETT'S OESOPHAGUS
|
№2 / 2015
|
|
V.V. Tsukanov, A.V. Vasyutin, Yu.L. Tonkikh, O.S. Amelchugova
THERAPY OF NONALCOHOLIC FATTY LIVER DISEASE. IS THERE A PLACE FOR HEPATOPROTECTORS?
|
№18 / 2014
|
|
A.A. Vizel, G.V. Lysenko
FEATURES OF THE MANAGEMENT OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN TATARSTAN
|
№15 / 2014
|
|
A.N. Surkov
GLYCOGEN DISEASE IN CHILDREN: THE PROBLEM OF DIAGNOSIS AND TREATMENT
|
№11 / 2014
|
|
A.R. Tatarsky, D.A. Kirillova
DIFFERENTIATED APPROACH TO THE CHOICE OF STARTING THERAPY IN COPD
|
№s4-14 / 2014
|
Русский
